Edward Carr, CHIEF ACCOUNTING OFFICER at Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 43,682 shares at $80.71 ($3.6M) on 2026-03-12, disclosed to the SEC on 2026-03-13.
Open-market sale of $3.6M DNTH by CHIEF ACCOUNTING OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.71 | 15,852 | $1.3M | 35.9% |
| 2 | $81.75 | 23,465 | $1.9M | 53.9% |
| 3 | $82.66 | 3,865 | $319K | 9.0% |
| 4 | $83.38 | 200 | $17K | 0.5% |
| 5 | $85.53 | 300 | $26K | 0.7% |
| Total | $81.49 avg | 43,682 |
| $3.6M |
| 100% |
| Filing → |
| ABEO | SELL | 2021-04-05 | $101K | — | Filing → |
| ABEO | SELL | 2020-03-20 | $12K | — | Filing → |